Cargando…

Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases

BACKGROUND: Proteinase-activated receptor 2 (PAR-2) has been shown to promote both neurotoxic and neuroprotective effects. Similarly, other routinely used nonspecific markers of neuronal damage can be found in cerebrospinal fluid (CSF) and can be used as biomarkers for different neurodegenerative di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohan, Zdenek, Smetakova, Magdalena, Kukal, Jaromir, Rusina, Robert, Matej, Radoslav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392746/ https://www.ncbi.nlm.nih.gov/pubmed/25886404 http://dx.doi.org/10.1186/s12883-015-0300-x

Ejemplares similares

Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up
por: Bruzova, Magdalena, et al.
Publicado: (2021)

Biomarkers Analysis and Clinical Manifestations in Comorbid Creutzfeldt–Jakob Disease: A Retrospective Study in 215 Autopsy Cases
por: Jankovska, Nikol, et al.
Publicado: (2022)

Use of fuzzy edge single-photon emission computed tomography analysis in definite Alzheimer's disease - a retrospective study
por: Rusina, Robert, et al.
Publicado: (2010)

PAR-2, IL-4R, TGF-β and TNF-α in bronchoalveolar lavage distinguishes extrinsic allergic alveolitis from sarcoidosis
por: MATĚJ, RADOSLAV, et al.
Publicado: (2014)

Pyramidal system involvement in progressive supranuclear palsy – a clinicopathological correlation
por: Stejskalova, Zuzana, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2022)

Comorbid Neurodegeneration in Primary Progressive Aphasia: Clinicopathological Correlations in a Single-Center Study
por: Rusina, Robert, et al.
Publicado: (2022)

PART and ARTAG tauopathies at a relatively young age as a concomitant finding in sporadic Creutzfeldt-Jakob disease
por: Menšíková, Kateřina, et al.
Publicado: (2021)

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
por: Jesse, Sarah, et al.
Publicado: (2010)

Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
por: Wakamatsu, Keiji, et al.
Publicado: (2022)

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
por: Schmitz, Matthias, et al.
Publicado: (2022)

Human Prion Disorders: Review of the Current Literature and a Twenty-Year Experience of the National Surveillance Center in the Czech Republic
por: Jankovska, Nikol, et al.
Publicado: (2021)

Exploratory mass spectrometry of cerebrospinal fluid from persons with autopsy-confirmed LATE-NC
por: Gal, Jozsef, et al.
Publicado: (2023)

Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers
por: Berger, Miles, et al.
Publicado: (2022)

Low activity of complement in the cerebrospinal fluid of the patients with various prion diseases
por: Chen, Cao, et al.
Publicado: (2016)

Prion-Seeding Activity in Cerebrospinal Fluid of Deer with Chronic Wasting Disease
por: Haley, Nicholas J., et al.
Publicado: (2013)

Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
por: Vallabh, Sonia M., et al.
Publicado: (2020)

Editorial: Prion and prion-like proteins in neurodegenerative diseases
por: Toni, Mattia, et al.
Publicado: (2022)

From Prion Diseases to Prion-Like Propagation Mechanisms of Neurodegenerative Diseases
por: Acquatella-Tran Van Ba, Isabelle, et al.
Publicado: (2013)

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort
por: Niemantsverdriet, Ellis, et al.
Publicado: (2018)

Rapid amplification of prions from variant Creutzfeldt–Jakob disease cerebrospinal fluid
por: Barria, Marcelo A, et al.
Publicado: (2018)

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

The Role of Iron in Prion Disease and Other Neurodegenerative Diseases
por: Singh, Neena
Publicado: (2014)

Cognitive impairment in cerebellar lesions: a logit model based on neuropsychological testing
por: Bolceková, Eva, et al.
Publicado: (2017)

Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin
por: Cronier, Sabrina, et al.
Publicado: (2008)

Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and miRNAs as Biomarkers for Prion Diseases
por: López-Pérez, Óscar, et al.
Publicado: (2021)

Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid
por: Meda, Francisco J., et al.
Publicado: (2023)

Association between Cerebrospinal Fluid Soluble TREM2, Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Zhou, Wenchuan, et al.
Publicado: (2023)

Modulation of Mitochondrial Dynamics in Neurodegenerative Diseases: An Insight Into Prion Diseases
por: Zhu, Ting, et al.
Publicado: (2018)

Relationships between Clinicopathological Features and Cerebrospinal Fluid Biomarkers in Japanese Patients with Genetic Prion Diseases
por: Higuma, Maya, et al.
Publicado: (2013)

Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease
por: Lowes, Hannah, et al.
Publicado: (2020)

Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
por: Gouras, Gunnar K.
Publicado: (2013)

Targeting prion-like protein spreading in neurodegenerative diseases
por: Zhang, Zhaohui, et al.
Publicado: (2018)

Proteinase K resistant cores of prions and amyloids
por: Kushnirov, Vitaly V., et al.
Publicado: (2019)

Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Cerebrospinal fluid sampling for research of Alzheimer’s disease and other neurodegenerative diseases when lumbar punctures are performed by anaesthetists
por: Atkins, Kelly J, et al.
Publicado: (2022)

Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients
por: Zerr, Inga, et al.
Publicado: (2019)

Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study
por: Kaipainen, Aku, et al.
Publicado: (2020)

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
por: Minta, K., et al.
Publicado: (2020)

Characterization of cerebrospinal fluid biomarkers associated with neurodegenerative diseases in healthy cynomolgus and rhesus macaque monkeys
por: Robertson, Emma L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4kt5kvh57o7j7hmedu5qfinb9h